Efficacy News and Research

RSS
Vitro Diagnostics' novel stem cell technology for cancer treatment

Vitro Diagnostics' novel stem cell technology for cancer treatment

Esperance Pharmaceuticals begins human clinical trials of its EP-100 cancer therapeutic candidate

Esperance Pharmaceuticals begins human clinical trials of its EP-100 cancer therapeutic candidate

Human neural stem cells to treat Pelizaeus-Merzbacher Disease

Human neural stem cells to treat Pelizaeus-Merzbacher Disease

Phase III trial demonstrates rapid efficacy of Zelrix in treating acute migraine

Phase III trial demonstrates rapid efficacy of Zelrix in treating acute migraine

Quatrx' second phase 3 study of ospemifene tablets provides positive results

Quatrx' second phase 3 study of ospemifene tablets provides positive results

NovaBay begins clinical studies for treating impetigo skin infection

NovaBay begins clinical studies for treating impetigo skin infection

FDA removes clinical hold on HEPLISAV hepatitis B vaccine

FDA removes clinical hold on HEPLISAV hepatitis B vaccine

Affymax to complete Hematide Phase 3 clinical study by the end of 2009

Affymax to complete Hematide Phase 3 clinical study by the end of 2009

Labopharm to present its novel trazodone formulation data

Labopharm to present its novel trazodone formulation data

Efficacy of Ore Pharmaceuticals' lead drug candidate discussed

Efficacy of Ore Pharmaceuticals' lead drug candidate discussed

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Biovista's BVA-201 drug for MS shows positive results

Biovista's BVA-201 drug for MS shows positive results

Galapagos starts new clinical trial for GLPG0259

Galapagos starts new clinical trial for GLPG0259

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee

GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee

Patient enrollment completed in Phase 2b clinical trial for Pyridorin

Patient enrollment completed in Phase 2b clinical trial for Pyridorin

Merck's GARDASIL receives approval from FDA Advisory Committee

Merck's GARDASIL receives approval from FDA Advisory Committee

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

Medpro completes preliminary testing and regulatory requirements for its VACUETTE safety needle system

AOLS to initiate clinical study for testing the efficacy of AEOL 10150

AOLS to initiate clinical study for testing the efficacy of AEOL 10150

VIVUS' Phase 3 studies find Qnexa effective in tackling obesity

VIVUS' Phase 3 studies find Qnexa effective in tackling obesity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.